Financials
Financial year 2024
WEEXA BIOLOGICALS from Neupré, company number BE0791956795, closed financial year 2024 with a result of € 49,110 after tax. For that financial year WEEXA BIOLOGICALS recorded a gross margin of € 64,990 and equity of € 120,661. Compared with financial year 2023, the result moved from € 19,469 to € 49,110. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 24, 2025.
€ 120,661
▲ € 91,193 vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 49,110
▲ 152% vs 2023
Profit after tax over the fiscal year.
€ 96,174
▲ 60% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 68,578.
People and assets in 2024
€ 3,111
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 159
Loans from banks and other lenders, long and short.
€ 36,372
▲ 283% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 1,863
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|
| Gross margin | € 25,495 | € 64,990 | ▲ 155% |
| Profit after taxes | € 19,469 | € 49,110 | ▲ 152% |
| Equity | € 29,469 | € 120,661 | ▲ € 91,193 |
| Total debts | € 58,969 | € 72,291 | ▲ 23% |
| Cash | € 60,027 | € 96,174 | ▲ 60% |
| Retained profit | € 19,469 | € 68,578 | ▲ 252% |
| Bank debt | € 0 | € 159 | |
| Balance sheet total | € 88,437 | € 192,952 | ▲ 118% |
Key figures of WEEXA BIOLOGICALS, fiscal years 2023 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to WEEXA BIOLOGICALS?
What happened at WEEXA BIOLOGICALS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 49,110 (▲ 152% vs 2023). Source: NBB ↗
- New establishment in Gembloux. KBO
- Start of the company according to the CBE. KBO
- FW BIOCONSULT became a director. NBB
- PPP & NPK MANAGEMENT became a director. NBB
In short
From € 19,469 profit in 2023 to € 49,110 profit in 2024.
Paid € 16,459 in corporate taxes since 2023.
Best year ever: 2024, with € 49,110 profit.
A new publication or filing at WEEXA BIOLOGICALS? We notify you, reason included.
Follow WEEXA BIOLOGICALSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of FW Bioconsult comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
WEEXA BIOLOGICALSBehind WEEXA BIOLOGICALS are FW BIOCONSULT and PPP & NPK MANAGEMENT. The shares are held by FW Bioconsult (33.3%).
Directors
According to the 2024 annual accounts
Director · represented by Frédéric WEEKERS
since 2022
Director · represented by Xavier VANBEGIN
since 2022
Shareholders
33.3%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue Strivay(PLX) 67
4122 Neupré
Rue Haie Nicolas 42
5030 Gembloux
Active since 6 October 2022
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0791.956.795
- VAT number
- BE 0791.956.795
- Registered office
- Rue Strivay(PLX) 67, 4122 Neupré
- Names & denominations
- WEEXA BIOLOGICALS · WEEXA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 October 2022
- Peppol
- Active · Active since 30 Oct 2025
- Activities · NACE
Vervaardiging van kunstmeststoffen en stikstofverbindingen
Speur- en ontwikkelingswerk op biotechnologisch gebied
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Groothandel in kunstmeststoffen en andere agrochemische producten
Groothandel in andere akkerbouwproducten
Vervaardiging van verdelgingsmiddelen, ontsmettingsmiddelen en andere chemische producten voor de landbouw
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering